Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Contraceptive Efficacy and Body Weight
NCT00662454Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jan 2006
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ethinylestradiol + levonorgestrel in contraception (2 arms), sponsored by Oregon Health & Science University. Primary endpoint: Concentrations of circulating oral contraceptives dosed in a standard cyclic fashion in obese and normal BMI cohorts at 1 year. Started Jan 2006; status: completed.
02
Drugs
ethinylestradiol + levonorgestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00662454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00662454.